Author:
Vahid Eslami,Fatemeh Mortezapour,Shiva Samavat,Shadi Ziae,Azin Gheymati
Publisher
Peertechz Publications Private Limited
Reference36 articles.
1. 1. Williamson KM, Thrasher KA, Fulton KB, LaPointe NM, Dunham GD, et al. (1998) Digoxin toxicity: an evaluation in current clinical practice. Arch Intern Med 158: 2444-2449. Link: https://bit.ly/34DS4fx
2. 2. Englund G, Hallberg P, Artursson P, Michaëlsson K, Melhus H (2004) Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. BMC Med 2: 8. Link: https://bit.ly/3wTzLPs
3. 3. Gheorghiade M, Ferguson D (1991) Digoxin. A neurohormonal modulator in heart failure?. Circulation 84: 2181-2186. Link: https://bit.ly/3c8PL8E
4. 4. Vöhringer HF, Rietbrock N (1981) Digitalis therapy in renal failure with special regard to digitoxin. Int J Clin Pharmacol Ther Toxicol 19: 175-184. Link: https://bit.ly/2S6QSi5
5. 5. Yang EH, Shah S, Criley JM (2012) Digitalis toxicity: a fading but crucial complication to recognize. Am J Med 125: 337-343. Link: https://bit.ly/3wKkTTA